FDA approves Novavax’s COVID-19 vaccine for those 18 and older
July 13, 2022 at 16:45 PM EDT
U.S. health regulators have authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option that works differently than the two leading vaccines, but at a time when overall demand for vaccines and boosters is low.
